Alkem Laboratories Ltd - 539523 - Corporate Action-Board to consider Dividend
The record date for the purpose of payment of Interim Dividend for the Financial Year 2020-2021, would be Saturday, 13th February, 2021, subject to declaration of the said Interim Dividend by the Board of Directors in its meeting to be held on 05th February, 2021. Kindly take note of the same. Alkem Laboratories Ltd - 539523 - Corporate Action - Fixes Record Date For Interim Dividend
The record date for the purpose of payment of Interim Dividend for the Financial Year 2020-2021, would be Saturday, 13th February, 2021, subject to declaration of the said Interim Dividend by the Board of Directors in its meeting to be held on 05th February, 2021. Kindly take note of the same. Alkem Laboratories Ltd - 539523 - Board Meeting Intimation for Notice Of Meeting Of Board Of Directors Of The Company Scheduled To Be Held On 05Th February, 2021.
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2021 ,inter alia, to consider and approve (i) the Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2020; and (ii) Interim Dividend for the Financial Year 2020-2021. The record date for the purpose of payment of Interim Dividend for the Financial Year 2020-2021, would be Saturday, 13th February, 2021, subject to declaration of the said Interim Dividend by the Board of Directors in its meeting to be held on 05th February, 2021. Kindly take note of the same. Alkem Laboratories Ltd - 539523 - Shareholding for the Period Ended December 31, 2020
Alkem Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2020. For more details, kindly Click here Alkem Laboratories Ltd - 539523 - Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Manish NarangDesignation :- Company Secretary and Compliance Officer Alkem Laboratories Ltd - 539523 - Disclosure of Voting results of Postal Ballot (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Alkem Laboratories Ltd has informed BSE regarding the details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Alkem Laboratories Ltd - 539523 - Details Of The Voting Results Of The Postal Ballot Through Remote E-Voting - Regulation 44(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
In continuation of our letter dated 27th November, 2020 and pursuant to provisions of Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the resolution as proposed in the Postal Ballot Notice dated 06th November, 2020 has been passed by the members of the Company with requisite majority. We are enclosing herewith the details regarding the voting results of the business transacted through Postal Ballot by remote e-voting process in the prescribed format alongwith the Scrutinizer's Report. The same are also being uploaded on Company's website. The approval is deemed to have been received on the last date of remote e-voting, i.e. 27th December, 2020. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Closure of Trading Window
This is to inform you that in terms of Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders, the trading window will remain closed from 30th December, 2020 until the expiry of 48 hours after the date on which the Financial Results of the Company for the quarter and nine months ended 31st December, 2020 are communicated to the Stock Exchanges. Alkem Laboratories Ltd - 539523 - Disclosure Of Related Party Transactions On A Consolidated Basis Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed disclosures of related party transactions, on a consolidated basis, for the half year ended on 30th September, 2020 in the prescribed format. The same have been published on the website of the Company at www.alkemlabs.com. Kindly take the same on record. Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to Regulation 30 and 47 read alongwith Schedule Ill of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015 ("the Regulation"}, please find enclosed herewith a copy of advertisement published in today''s Newspapers viz. Business Standard (English) and Lakshadweep (Marathi) regarding Postal Ballot Notice and E-Voting Information. The same is also available on the website of the Company at www.alkemlabs.com. Kindly take the same on record.